Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients

被引:3
|
作者
Cruz, Aline C. [1 ]
Neves, Bianca C. [2 ]
Higa, Laurinda Y. S. [3 ]
Folescu, Tania [3 ]
Marques, Elizabeth A. [1 ]
Milagres, Lucimar G. [1 ]
机构
[1] Univ Estado Rio de Janeiro, Dept Microbiol Imunol & Parasitol, BR-20550170 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Rio De Janeiro, RJ, Brazil
[3] Fiocruz MS, Fernandes Figueira Inst, Dept Pulmonol, BR-21045900 Rio De Janeiro, RJ, Brazil
关键词
Antibody response; P; aeruginosa; pulmonary infection; diagnosis; cystic fibrosis; V-ANTIGEN; CHILDREN;
D O I
10.1111/j.1600-0463.2012.02888.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pseudomonas aeruginosa is associated with increased mortality in cystic fibrosis (CF) patients, and expresses type III secretion system proteins (TTSP), which is a common mechanism used by gram-negative pathogens for delivery of anti-host factors. Our aim was to investigate whether or not these antigens (TTSP) would be recognized by CF sera, by Western blot reaction. We have showed herein that all patients (n = 11) not chronically infected by P. aeruginosa had their first serum positive for TTSP (ExoS, ExoT, PopB, and/or PopD). All chronic patients had a strong positive serology to TTSP, although relatively weak reactions to TTSP were observed for some individuals in the negative control group. Therefore, TTSP that were early produced in P. aeruginosa infected CF patients, induced a detectable antibody response in those patients and were easily detected by Western-blot reaction.
引用
收藏
页码:622 / 627
页数:6
相关论文
共 50 条
  • [1] Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus
    Moss, J
    Ehrmantraut, ME
    Banwart, BD
    Frank, DW
    Barbieri, JT
    [J]. INFECTION AND IMMUNITY, 2001, 69 (02) : 1185 - 1188
  • [2] Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Taccetti, G
    Campana, S
    Marianelli, L
    [J]. JOURNAL OF PEDIATRICS, 1996, 129 (04): : 619 - 620
  • [3] Cytokine Expression In Cystic Fibrosis Patients With Pseudomonas AerugINOSa Infection And Pulmonary Exacerbations
    Cardenas, S. C.
    Samsell, L. J.
    Walton, C.
    Worley, S.
    Piedimonte, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [4] Antimicrobial treatment of pulmonary colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients
    Denton, M
    Wilcox, MH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) : 468 - 474
  • [5] Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection
    Jain, Manu
    Bar-Meir, Maskit
    Mccolley, Susanna
    Cullina, Joanne
    Potter, Eileen
    Powers, Cathy
    Prickett, Michelle
    Seshadri, Roopa
    Jovanovic, Borko
    Petrocheilou, Argyri
    King, John D.
    Hauser, Alan R.
    [J]. TRANSLATIONAL RESEARCH, 2008, 152 (06) : 257 - 264
  • [6] Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa
    Pitt, TL
    [J]. THORAX, 2002, 57 (11) : 921 - 921
  • [7] Pseudomonas aeruginosa infection in patients with cystic fibrosis - Reply
    Lang, AB
    [J]. JOURNAL OF PEDIATRICS, 1996, 129 (04): : 620 - 620
  • [8] Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Doering, Gerd
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (08) : 573 - 577
  • [9] Pseudomonas aeruginosa infection and cystic fibrosis
    Kato, K
    Takayama, T
    [J]. LANCET, 2002, 359 (9302): : 262 - 262
  • [10] Pseudomonas aeruginosa infection in cystic fibrosis
    Hoiby, Niels
    [J]. APMIS, 2007, 115 (05) : 621 - 628